Views: 24 Author: Medlere Publish Time: 2022-10-21 Origin: www.medlere.com
(Xiamen China, October 21, 2022) - Medlere Limited, a pioneering healthcare technology company, is delighted to announce its entry into the field of animal diagnostics, providing a wide array of diagnostic solutions for both human and animal. This strategic expansion marks a significant milestone for Medlere Limited, demonstrating its commitment to advancing healthcare outcomes across various sectors.
With a proven track record in human diagnostics, Medlere Limited is leveraging its expertise and innovative technologies to enhance the field of animal healthcare. The company now offers a comprehensive suite of testing services tailored for both human and animal patients, ensuring accurate and timely diagnoses for a multitude of health conditions.
"Our foray into animal testing represents a natural progression for Medlere Limited. By extending our diagnostic capabilities to animal testing, we aim to bridge the gap between human and animal healthcare, providing holistic solutions for families and their beloved pets," said CTO of Medlere Limited. "We believe that the expertise we have developed in human diagnostics can be seamlessly applied to the animal kingdom, ultimately improving the well-being of both humans and animals."
Medlere Limited's expansion into animal testing encompasses a wide range of diagnostic services, including but not limited to blood tests, imaging, pathology, and genetic testing. These services are designed to cater to the diverse healthcare needs of both human patients and animals, ensuring comprehensive and accurate diagnostics across the board.
The company's state-of-the-art laboratories, staffed with experienced professionals and equipped with cutting-edge technology, guarantee the highest standards of accuracy and reliability in all diagnostic procedures. Medlere Limited remains dedicated to advancing medical science and enhancing the quality of healthcare services globally.
About Medlere Limited:
Medlere Limited is a leading healthcare technology company dedicated to providing innovative in vitro diagnostic solutions and patient-centric services. With a focus on advancing healthcare outcomes, Medlere Limited leverages cutting-edge technology and international expertise to enhance the accessibility and quality of healthcare services globally. For more information, please visit www.medlere.com or contact: info@medlere.com
